Multiple organ dysfunction: Baseline and serial component scores

被引:79
作者
Cook, R [1 ]
Cook, D
Tilley, J
Lee, KA
Marshall, J
机构
[1] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
[2] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada
[3] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada
[4] Univ Toronto, Dept Surg, Toronto, ON, Canada
关键词
organ dysfunction; multiple organ dysfunction; organ failure; critical care; intensive care unit; mortality;
D O I
10.1097/00003246-200111000-00002
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The multiple organ dysfunction score (MODS) describes and quantifies organ-specific physiology. The objective of this study was to examine the relation between six components of MODS (cardiovascular, respiratory, renal, central nervous system, hepatic, and hematologic) measured at admission to the intensive core unit (ICU) and during the ICU stay, with time to death in the ICU. Design: Prospective observational cohort study. Setting. Sixteen Canadian ICUs. Patients., A total of 1,200 patients were mechanically ventilated for > 48 hrs. Measurements and Main Results. The six organ systems comprising MODS were measured at ICU admission (baseline scores) and daily thereafter. The change in organ dysfunction each day (serial scores) were calculated as daily component scores minus the corresponding baseline component scores. In Cox regression analyses, the independent explanatory variables were the MODS components measured at baseline and serially, and the dependent variable was the time from admission to ICU mortality. When each organ system was analyzed individually, both the baseline and serial MODS for the cardiovascular, respiratory, renal, central nervous system, and hematologic components were significantly associated with ICU mortality. After adjusting for the serial hepatic score, the baseline hepatic score was unrelated to mortality. After adjusting for all baseline and serial MODS components in aggregate, four organ systems were significantly associated with ICU mortality: cardiovascular (baseline relative risk [RR], 1.5; serial RR, 1.4); respiratory (baseline RR, 1.4; serial RR, 1.4); renal (baseline RR, 1.3; serial RR, 1.5); and central nervous system (baseline RR, 1.6; serial RR, 1.7). We found that the relative risk of mortality related to organ dysfunction varied significantly over time and among organ systems. Baseline respiratory function was not associated with mortality until the second ICU week (week 1: RR, 1.1 [0.9-1.4]; week 2 onward: RR, 1.9 [1.5-2.4]); the same was true for the change in respiratory function as measured by the serial respiratory score (week 1: RR, 1.2 [1.0-1.5]; week 2 onward: RR, 1.7 [1.4-2.1]). The serial hepatic score was not associated with mortality until the fourth ICU week (weeks 1-3: RR, 0,9 [0.7-1.1]; week 4 onward: RR, 1.4 [1.0-2.0]). Conclusions: Organ dysfunction scores describe physiology at ICU admission and during ICU stay. Although patterns vary by system, daily MODS component scores provide additional prognostic value over baseline MODS.
引用
收藏
页码:2046 / 2050
页数:5
相关论文
共 38 条
[1]   E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis - A randomized controlled trial [J].
Angus, DC ;
Birmingham, MC ;
Balk, RA ;
Scannon, PJ ;
Collins, D ;
Kruse, JA ;
Graham, DR ;
Dedhia, HV ;
Homann, S ;
MacIntyre, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13) :1723-1730
[2]  
BAUE AE, 1975, ARCH SURG-CHICAGO, V110, P779
[3]   MULTIPLE ORGAN FAILURE SYNDROME IN THE 1990S - SYSTEMIC INFLAMMATORY RESPONSE AND ORGAN DYSFUNCTION [J].
BEAL, AL ;
CERRA, FB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :226-233
[4]  
BERNARD GR, 1995, AM J RESP CRIT CARE, V151, pA323
[5]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[6]   Users' guides to the medical literature XIX. Applying clinical trial results A. How to use an article measuring the effect of an intervention on surrogate end points [J].
Bucher, HC ;
Guyatt, GH ;
Cook, DJ ;
Holbrook, A ;
McAlister, FA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (08) :771-778
[7]  
BURDEN RL, NUMERICAL ANAL, P98
[8]   A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation [J].
Cook, D ;
Guyatt, G ;
Marshall, J ;
Leasa, D ;
Fuller, H ;
Hall, R ;
Peters, S ;
Rutledge, F ;
Griffith, L ;
McLellan, A ;
Wood, G ;
Kirby, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12) :791-797
[9]   RISK-FACTORS FOR GASTROINTESTINAL-BLEEDING IN CRITICALLY ILL PATIENTS [J].
COOK, DJ ;
FULLER, HD ;
GUYATT, GH ;
MARSHALL, JC ;
LEASA, D ;
HALL, R ;
WINTON, TL ;
RUTLEDGE, F ;
TODD, TJR ;
ROY, P ;
LACROIX, J ;
GRIFFITH, L ;
WILLAN, A ;
NOSEWORTHY, T ;
POWLES, P ;
OPPENHEIMER, L ;
HEWSON, J ;
LANG, J ;
LEE, H ;
GUSLITS, B ;
HEULE, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (06) :377-381
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187